Implementation of a CKD checklist for primary care providers.

BACKGROUND AND OBJECTIVES CKD is associated with significant morbidity, mortality, and financial burden. Practice guidelines outlining CKD management exist, but there is limited application of these guidelines. Interventions to improve CKD guideline adherence have been limited. This study evaluated a new CKD checklist (a tool outlining management guidelines for CKD) to determine whether implementation in an academic primary care clinic improved adherence to guidelines. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS During a 1-year period (August 2012-August 2013), a prospective study was conducted among 13 primary care providers (PCPs), four of whom were assigned to use a CKD checklist incorporated into the electronic medical record during visits with patients with CKD stages 1-4. All providers received education regarding CKD guidelines. The intervention and control groups consisted of 105 and 263 patients, respectively. Adherence to CKD management guidelines was measured. RESULTS A random-effects logistic regression analysis was performed to account for intra-group correlation by PCP assignment and adjusted for age and CKD stage. CKD care improved among patients whose PCPs were assigned to the checklist intervention compared with controls. Patients in the CKD checklist group were more likely than controls to have appropriate annual laboratory testing for albuminuria (odds ratio [OR], 7.9; 95% confidence interval [95% CI], 3.6 to 17.2), phosphate (OR, 3.5; 95% CI, 1.5 to 8.3), and parathyroid hormone (OR, 8.1; 95% CI, 4.8 to 13.7) (P<0.001 in all cases). Patients in the CKD checklist group had higher rates of achieving a hemoglobin A1c target<7% (OR, 2.7; 95% CI, 1.4 to 5.1), use of an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker (OR, 2.1; 95% CI, 1.0 to 4.2), documentation of avoidance of nonsteroidal anti-inflammatory drugs (OR, 41.7; 95% CI, 17.8 to 100.0), and vaccination for annual influenza (OR, 2.1; 95% CI, 1.1 to 4.0) and pneumococcus (OR, 4.7; 95% CI, 2.6 to 8.6) (P<0.001 in all cases). CONCLUSIONS Implementation of a CKD checklist significantly improved adherence to CKD management guidelines and delivery of CKD care.

[1]  D. Elbourne,et al.  Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects☆ , 2014, Journal of clinical epidemiology.

[2]  K. Inaba,et al.  Measurable outcomes of quality improvement using a daily quality rounds checklist: Two-year prospective analysis of sustainability in a surgical intensive care unit , 2013, The journal of trauma and acute care surgery.

[3]  A. Levin,et al.  Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.

[4]  Roland E Schmieder,et al.  Clinical situations associated with difficult-to-control hypertension , 2013, Journal of hypertension.

[5]  C. Bridges,et al.  Recommended adult immunization schedule-United States, 2013. , 2013, Journal of midwifery & women's health.

[6]  Stephen D. Persell,et al.  Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysis , 2012, BMC Health Services Research.

[7]  J. Timsit,et al.  A multifaceted program for improving quality of care in intensive care units: IATROREF study* , 2012, Critical care medicine.

[8]  J. Weissfeld,et al.  Comorbidity as a Mediator of Survival Disparity Between Younger and Older Women Diagnosed With Metastatic Breast Cancer , 2012, Hypertension.

[9]  Keith C. Norris,et al.  Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). , 2012, Archives of internal medicine.

[10]  M. Landray,et al.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.

[11]  Abigail Shefer,et al.  Recommended Adult Immunization Schedule: United States, 2011* , 2011, Annals of Internal Medicine.

[12]  Raquel C. Greer,et al.  Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions , 2011, BMC nephrology.

[13]  David W. Bates,et al.  Primary Care Management of Chronic Kidney Disease , 2011, Journal of General Internal Medicine.

[14]  S. de Lusignan,et al.  Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[15]  D. Jonas,et al.  Systematic Review: Enhancing the Use and Quality of Colorectal Cancer Screening , 2010, Annals of Internal Medicine.

[16]  V. Jeevanantham,et al.  Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. , 2010, Clinical nephrology.

[17]  Ian J. Stewart,et al.  Chronic kidney disease management in an academic internal medicine clinic , 2010, Clinical and Experimental Nephrology.

[18]  W. Berry,et al.  A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population , 2009, The New England journal of medicine.

[19]  Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  S. Derose,et al.  Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Spyridon S Marinopoulos,et al.  The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. , 2008, Journal of clinical epidemiology.

[22]  Chester H. Fox,et al.  Improving Chronic Kidney Disease Care in Primary Care Practices: An Upstate New York Practice-based Research Network (UNYNET) Study , 2008, The Journal of the American Board of Family Medicine.

[23]  K. Kalantar-Zadeh,et al.  Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[24]  Daniel C. Brennan,et al.  Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review , 2008, Clinical and Experimental Nephrology.

[25]  A. Gawande,et al.  The checklist: if something so simple can transform intensive care, what else can it do? , 2007, New Yorker.

[26]  H. Manley Disease Progression and the Application of Evidence-Based Treatment Guidelines Diagnose It Early: A Case for Screening and Appropriate Management , 2007, Journal of managed care pharmacy : JMCP.

[27]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[28]  Dose conversions: opportunity for error. , 2007, The American journal of medicine.

[29]  J. Goddard,et al.  What are the best treatments for early chronic kidney disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  Jerome D. Cohen,et al.  Overview of physiology, vascular biology, and mechanisms of hypertension. , 2007, Journal of managed care pharmacy : JMCP.

[31]  J. Ingelfinger Through the looking glass: anemia guidelines, vested interests, and distortions. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[32]  M. Tonelli,et al.  NSAID use and progression of chronic kidney disease. , 2007, The American journal of medicine.

[33]  N. Powe,et al.  Identification and referral of patients with progressive CKD: a national study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  H. Clark,et al.  Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  G. Bakris,et al.  The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. , 2005, Archives of internal medicine.

[36]  Evelyn P Whitlock,et al.  Screening for Abdominal Aortic Aneurysm: A Best-Evidence Systematic Review for the U.S. Preventive Services Task Force , 2005, Annals of Internal Medicine.

[37]  Zhongxin Zhang,et al.  Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.

[38]  A. Kausz,et al.  The Value of Vaccination in Chronic Kidney Disease , 2004, Seminars in dialysis.

[39]  Neil R. Powe,et al.  Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease , 2003, Epidemiology.

[40]  G. Eknoyan Meeting the challenges of the new K/DOQI guidelines. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[42]  S. Woolf,et al.  Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[43]  R. Poveda,et al.  Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  Kdoqi Disclaimer K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  C. Schmid,et al.  Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.

[47]  C. Schmid,et al.  Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. , 2001, Annals of internal medicine.

[48]  B. Pereira,et al.  Optimization of pre-ESRD care: the key to improved dialysis outcomes. , 2000, Kidney international.

[49]  L. Agodoa,et al.  United States Renal Data System (USRDS). , 2000, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[50]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[51]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[52]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[53]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[54]  T. Louis,et al.  Long-term effects of antihypertensive agents on proteinuria and renal function. , 1995, Archives of internal medicine.

[55]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[56]  S. Klahr The modification of diet in renal disease study. , 1989, The New England journal of medicine.